ES2102087T3 - Procedimiento para la sintesis de glucosaminoglucanos semisinteticos con estructura de heparina o heparano modificada en la posicion 2 del acido alfa-l-iduronico-2-o-sulfato. - Google Patents

Procedimiento para la sintesis de glucosaminoglucanos semisinteticos con estructura de heparina o heparano modificada en la posicion 2 del acido alfa-l-iduronico-2-o-sulfato.

Info

Publication number
ES2102087T3
ES2102087T3 ES94104306T ES94104306T ES2102087T3 ES 2102087 T3 ES2102087 T3 ES 2102087T3 ES 94104306 T ES94104306 T ES 94104306T ES 94104306 T ES94104306 T ES 94104306T ES 2102087 T3 ES2102087 T3 ES 2102087T3
Authority
ES
Spain
Prior art keywords
heparin
alpha
synthesis
glucosaminoglucans
heparane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94104306T
Other languages
English (en)
Inventor
Fabrizio Ungarelli
Silvano Piani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfa Wasserman SpA
Original Assignee
Alfa Wasserman SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wasserman SpA filed Critical Alfa Wasserman SpA
Application granted granted Critical
Publication of ES2102087T3 publication Critical patent/ES2102087T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE DESCRIBE UN PROCESO PARA LA SINTESIS DE GLICOSAMINOGLICANOS SEMISINTETICOS DE LA FORMULA GENERAL III CON UNA ESTRUCTURA DE HEPARINA O HEPARAN MODIFICADA EN LA POSICION 2 DEL ACIDO DEL (ALFA)-LIDURONIC-2-O-SULFATO EN DONDE EL GRUPO SULFATO ES, TOTALMENTE O EN PARTE, SUSTITUIDO POR UN RADICAL NUCLEOFILICO. DICHO PROCESO SE LLEVA A CABO TRATANDO GLICOSAMINOGLICANOS CON UNA ESTRUCTURA DE HEPARINA O DE HEPARAN MEDIANTE UN AGENTE NUCLEOFILICO EN UN MEDIO ALCALINO.
ES94104306T 1993-03-29 1994-03-18 Procedimiento para la sintesis de glucosaminoglucanos semisinteticos con estructura de heparina o heparano modificada en la posicion 2 del acido alfa-l-iduronico-2-o-sulfato. Expired - Lifetime ES2102087T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93BO000125A IT1264101B1 (it) 1993-03-29 1993-03-29 Processo per la sintesi di glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2

Publications (1)

Publication Number Publication Date
ES2102087T3 true ES2102087T3 (es) 1997-07-16

Family

ID=11338858

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94104306T Expired - Lifetime ES2102087T3 (es) 1993-03-29 1994-03-18 Procedimiento para la sintesis de glucosaminoglucanos semisinteticos con estructura de heparina o heparano modificada en la posicion 2 del acido alfa-l-iduronico-2-o-sulfato.

Country Status (18)

Country Link
US (1) US5405949A (es)
EP (1) EP0618234B1 (es)
JP (1) JP2731721B2 (es)
KR (1) KR100194122B1 (es)
AT (1) ATE154039T1 (es)
AU (1) AU664939B2 (es)
CA (1) CA2114862C (es)
DE (1) DE69403537T2 (es)
DK (1) DK0618234T3 (es)
ES (1) ES2102087T3 (es)
FI (1) FI105101B (es)
GR (1) GR3024416T3 (es)
IL (1) IL108689A (es)
IT (1) IT1264101B1 (es)
NO (1) NO305994B1 (es)
NZ (1) NZ250815A (es)
TW (1) TW266215B (es)
ZA (1) ZA94970B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6255295B1 (en) 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
US7259152B2 (en) 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
AU2002243630A1 (en) 2001-01-23 2002-08-06 Massachusetts Institute Of Technology Solid- and solution -phase synthesis of heparin and other glycosaminoglycans
CZ307433B6 (cs) 2001-09-12 2018-08-22 Leadiant Biosciences Sa Deriváty částečně desulfátovaných glykosaminoglykanů jako inhibitory heparanázy mající antiangiogenní účinky a zabraňující antikoagulačnímu působení
GB0216861D0 (en) * 2002-07-19 2002-08-28 Univ Birmingham Saccharide libraries
DK3428175T3 (da) * 2016-03-09 2024-11-11 Glytech Inc Fremgangsmåde til fremstilling af oligosaccharider og polysaccharider med ikke-beskyttede sulfat-grupper
WO2021128253A1 (zh) * 2019-12-27 2021-07-01 深圳市海普瑞药业集团股份有限公司 一种糖胺聚糖衍生物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987223A (en) * 1981-12-23 1991-01-22 Choay S.A. Derivatives of the uronic acid
US6174999B1 (en) * 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
IT1234508B (it) * 1988-06-10 1992-05-19 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
IT1234826B (it) * 1989-01-30 1992-05-29 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
US5011919A (en) * 1989-01-30 1991-04-30 Ajorca S.A. Modified heparins and obtention process
IT1242604B (it) * 1990-11-13 1994-05-16 Alfa Wassermann Spa Sali di glicosaminoglicani con esteri di aminoacidi, loro preparazione e formulazioni farmaceutiche che li contengono.
IT1260136B (it) * 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonicosostituito con radicali nucleofili in posizione 3
IT1260137B (it) * 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2 dell'acido alfa-l-iduronico-2-0-solfato
BE1006134A6 (fr) * 1992-08-25 1994-05-24 Syntex Sa Procede de preparation de derives 2-desoxy-2-amino hexuronyles d'heparine, derives tels qu'ainsi obtenus et leur utilisation.

Also Published As

Publication number Publication date
IL108689A0 (en) 1994-05-30
ITBO930125A1 (it) 1994-09-29
FI941431L (fi) 1994-09-30
DK0618234T3 (da) 1997-08-25
EP0618234B1 (en) 1997-06-04
FI105101B (fi) 2000-06-15
AU5508594A (en) 1994-10-06
CA2114862A1 (en) 1994-09-30
ATE154039T1 (de) 1997-06-15
NO305994B1 (no) 1999-08-30
IL108689A (en) 1998-03-10
NO941128D0 (no) 1994-03-28
KR100194122B1 (ko) 1999-06-15
FI941431A0 (fi) 1994-03-28
IT1264101B1 (it) 1996-09-10
ITBO930125A0 (it) 1993-03-29
JPH06298805A (ja) 1994-10-25
US5405949A (en) 1995-04-11
TW266215B (es) 1995-12-21
DE69403537D1 (de) 1997-07-10
EP0618234A1 (en) 1994-10-05
GR3024416T3 (en) 1997-11-28
NZ250815A (en) 1996-02-27
KR940021582A (ko) 1994-10-19
ZA94970B (en) 1994-08-24
AU664939B2 (en) 1995-12-07
DE69403537T2 (de) 1997-09-18
JP2731721B2 (ja) 1998-03-25
NO941128L (no) 1994-09-30
CA2114862C (en) 1999-05-25

Similar Documents

Publication Publication Date Title
FI933656A0 (fi) 2,4-diaminokinazolinderivat, som foerstaerker antitumoeraktivitet
DE2962780D1 (en) Hyaluronidase and its production
FI921428A0 (fi) Process foer enzymatisk framstaellning av en basisk fibroblastvaextfaktor.
GR3022165T3 (en) Anti-virus agent
ES2102087T3 (es) Procedimiento para la sintesis de glucosaminoglucanos semisinteticos con estructura de heparina o heparano modificada en la posicion 2 del acido alfa-l-iduronico-2-o-sulfato.
EP0565863A3 (en) Semi-synthetic glycosaminoglycans with heparin or heparan structure of alpha-l-iduronic-2-0-sulfate acid modified in position 2
EP0263435A3 (en) An aromatic substituted glycoside
DE59001418D1 (de) Antikoagulanz enthaltendes mittel.
ES2029787T3 (es) Procedimiento para la preparacion de (2,2)-paraciclofanos halogenados y mezclas de (2,2)-paraciclofanos halogenados resultantes.
EP0424351A3 (en) Modified heparin cofactor ii
FI910421A0 (fi) Foerfarande foer bearbetning av binaera svavelfoereningar.
EP0648797A3 (en) Process for the production of low corrosive polyarylene sulfides.
ATE150468T1 (de) Dermatansulfatoligosaccharide, verfahren zu ihrer herstellung und diese enthaltende phamazeutische zusammensetzungen
ES2105382T3 (es) Procedimiento para la sintesis de glucosaminoglucanos semisinteticos que contienen acido alfa-l-galacturonico sustituido con radicales nucleofilos en posicion 3.
ES2086144T3 (es) Catalizador para la hidrolisis de sulfuro de carbonilo.
ES2051954T3 (es) 2-aminotiazoles substituidos.
GR78170B (es)
ES2062307T3 (es) Un proceso para la fabricacion de glicosaminoglicuronano sulfatado con actividad antitrombotica.
DK423084A (da) 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin b, dens 4ae-epimer og farmaceutisk acceptable salte deraf samt forbindelser til anvendelsen som mellemprodukter ved fremstilling deraf
KIM et al. A case of esophageal stricture by lye that treated with esophageal endoscopic endoprosthesis
DE69410379D1 (de) Verfahren zur Herstellung von Chloropren
RO102817A2 (ro) Derivati hidroxialchilhomopiperazinici ai teofilinei si procedeu de preparare a acestora

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 618234

Country of ref document: ES